Clinical trial
A Clinical Pharmacology Study of NPC-15 to Evaluate Arrhythmogenic Effect in Healthy Adults
NCT03475459 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Pharmacology Study of NPC-15 to Evaluate Arrhythmogenic Effect in Healthy Adults
- Lead sponsor
- Nobelpharma
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 3, 2018
- Completion date
- April 29, 2018
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
qt interval, variation in